Holen Sie sich die Stockscreener-App
10.96
5.60%
-0.65
Handel nachbörslich:
10.96
Schlusskurs vom Vortag:
$11.61
Offen:
$11.6
24-Stunden-Volumen:
64,114
Relative Volume:
1.27
Marktkapitalisierung:
$399.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-41.36M
KGV:
-6.6829
EPS:
-1.64
Netto-Cashflow:
$-42.09M
1W Leistung:
+1.20%
1M Leistung:
+35.64%
6M Leistung:
+284.56%
1J Leistung:
+442.57%
1-Tages-Spanne:
$10.78
$11.66
1-Wochen-Bereich:
$9.99
$11.81
52-Wochen-Spanne:
$0.8981
$16.34
Armata Pharmaceuticals Inc Stock (ARMP) Company Profile
Firmenname
Armata Pharmaceuticals Inc
Sektor
Branche
Telefon
310-655-2928
Adresse
4503 Glencoe Avenue, Marina del Rey, CA
Compare ARMP vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARMP
Armata Pharmaceuticals Inc
|
10.96 | 422.68M | 0 | -41.36M | -42.09M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.14 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Armata Pharmaceuticals Inc Stock (ARMP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-06-19 | Eingeleitet | Ladenburg Thalmann | Buy |
Armata Pharmaceuticals Inc Aktie (ARMP) Neueste Nachrichten
ARMPAmpliPhi Biosciences Announces Planned One-for-Ten Reverse Stock Split - ADVFN Ltd
H.C. Wainwright Reaffirms Buy on Armata Pharmaceuticals, Inc. (ARMP) After FDA Nod - Yahoo Finance
Weekly Buzz: MGNX's LINNET Trial On Hold; ETON, ALUR Get FDA Nod; GILD Snaps Up ACLX - RTTNews
ARMP Should I Buy - Intellectia AI
Armata Pharmaceuticals (ARMP) Price Target Increased by 25.00% to 15.30 - Nasdaq
ARMP: HC Wainwright & Co. Raises Price Target to $15 | ARMP Stoc - GuruFocus
Armata Pharmaceuticals stock gains on FDA designation By Investing.com - Investing.com Canada
Armata Pharmaceuticals stock gains on FDA designation - Investing.com India
Armata Pharmaceuticals (ARMP) Receives FDA Designation for AP-SA - GuruFocus
Armata Says FDA Grants Qualified Infectious Disease Product Designation to Complicated Bacteremia Treatment - marketscreener.com
Armata Gains QIDP Status for AP-SA02 Bacteremia Therapy - TipRanks
Armata Pharmaceuticals receives FDA qualified infectious disease product designation - marketscreener.com
Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation - TradingView
Armata Pharmaceuticals wins FDA QIDP for AP-SA02, enabling 5 years exclusivity and Fast Track eligibility - TradingView
FDA grants QIDP designation to Armata (ARMP) phage therapy AP-SA02 - Stock Titan
Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02 - PR Newswire
Growth Value: What analysts say about Armata Pharmaceuticals Inc stock2025 Breakouts & Breakdowns & Fast Gain Stock Tips - baoquankhu1.vn
Options Flow: Is HFBL a turnaround storyMarket Volume Report & AI Driven Stock Movement Reports - baoquankhu1.vn
ARMP Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Sees Significant Increase in Short Interest - MarketBeat
Is Armata Pharmaceuticals Inc. a cyclical or defensive stockJuly 2025 Drop Watch & Safe Investment Capital Preservation Plans - mfd.ru
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Short Interest Update - MarketBeat
MACD Signal: What analysts say about Armata Pharmaceuticals Inc stockJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - baoquankhu1.vn
Armata Pharmaceuticals FY2025 EPS Boosted by HC Wainwright - MarketBeat
Aug Closing: What is RADCOM Ltds debt to equity ratioMarket Movers & High Accuracy Swing Trade Signals - baoquankhu1.vn
AI Stocks: Can Armata Pharmaceuticals Inc grow without external fundingMarket Volume Summary & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Armata Pharmaceuticals (ARMP) price target increased by 33.33% to 12.24 - MSN
Phage Therapy Market Set to Witness Significant Growth - openPR.com
Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX), Armata Pharmaceuticals (ARMP) and Halozyme (HALO) - The Globe and Mail
Armata Extends Innoviva Credit, Warrants and Voting Pact - The Globe and Mail
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Stock Price Up 2%Time to Buy? - MarketBeat
Armata Pharmaceuticals (ARMP) Surges 103.2%: Is This an Indication of Further Gains? - MSN
Will Armata Pharmaceuticals Inc. stock gain from lower inflationQuarterly Market Summary & Comprehensive Market Scan Reports - bollywoodhelpline.com
Published on: 2026-01-19 10:14:54 - baoquankhu1.vn
Armata Pharmaceuticals (ARMP) Price Target Increased by 33.33% to 12.24 - Nasdaq
Block Trades: Is Armata Pharmaceuticals Inc stock a smart retirement pickTrade Risk Assessment & Growth Focused Stock Pick Reports - baoquankhu1.vn
Armata Wins FDA Support to Advance Bacteriophage to Phase 3 - TipRanks
Armata Pharmaceuticals Advances AP-SA02 to Phase 3 Study - TradingView — Track All Markets
C O R R E C T I O N -- Armata Pharmaceuticals, Inc./ – Company Announcement - Financial Times
ARMP Stock Quote - richtv.io
Why Armata Pharmaceuticals Inc. (TG1N) stock is upgraded to buyJuly 2025 Weekly Recap & Target Return Focused Picks - ulpravda.ru
What valuation multiples suggest for Armata Pharmaceuticals Inc. stock2025 Technical Overview & Consistent Income Trade Recommendations - ulpravda.ru
Armata Pharmaceuticals, Inc. Common Stock (NY: ARMP - FinancialContent
Will Armata Pharmaceuticals Inc. stock benefit from upcoming earnings reportsMarket Trend Report & Entry and Exit Point Strategies - Улправда
Will Armata Pharmaceuticals Inc. stock continue dividend increases2025 Price Targets & Community Consensus Trade Alerts - Улправда
Trade Recap: Will Armata Pharmaceuticals Inc. stock deliver long term returnsJuly 2025 Catalysts & Accurate Entry/Exit Alerts - Улправда
Can Armata Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Risk Summary & Scalable Portfolio Growth Methods - ulpravda.ru
Will Armata Pharmaceuticals Inc. stock maintain dividend yield2025 Geopolitical Influence & Advanced Technical Signal Analysis - Улправда
Will Armata Pharmaceuticals Inc. stock pay special dividendsMarket Sentiment Review & Real-Time Stock Movement Alerts - Улправда
About Us | Oil & Gas JournalArmata Pharmaceuticals, Inc. Common Stock (NYSE:ARMP) Detailed Stock Data - FinancialContent
Finanzdaten der Armata Pharmaceuticals Inc-Aktie (ARMP)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.69%
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):